Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Elanco Animal Health Inc

ELAN · NYSE · CIK 0001739104 · Healthcare · Drug Manufacturers—Specialty & Generic

INSIDER SIGNAL

81.1 / 100

7 buyers · 7 purchase transaction lines · $1.7M gross purchase

WHY THIS SIGNAL?

Buyer breadthStrong
Purchase sizeModerate
RoleModerate
RecencyLow
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+35.0 / 35
Purchase size+19.4 / 25
Role+13.0 / 20
Recency+3.7 / 10
Conviction+10.0 / 10

What is holding the score back?

  • ⚠ Role scores low · most senior buyer: PRESIDENT, CEO AND DIRECTOR (CEO, chair and 10% owners score lowest)
  • ⚠ Purchase activity is becoming less recent
  • ✓ Cluster breadth is broad · 4+ insiders

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Kurzius Lawrence ErikDirector
○●
Herendeen PaulDirector
○●
Harrington Michael JDirector
○●
VanHimbergen Robert MEVP and CFO
○●
Scots-Knight DeniseDirector
○
McDonald Kirk PDirector
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 8 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS7
PURCHASE CONCENTRATION56%Largest buyer: Kurzius Lawrence Erik · $936.0K
CLUSTER BUYING · 15D5 insidersPeak activity: 2026-08-07–2026-08-20

Roles in the peak window: Director, EVP and CFO, GC AND CORP SEC. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

81.1 / 100

Latest recorded score

↓ -0.1 ptsversus the previous recorded snapshot
  1. 81.5
  2. 81.4
  3. 81.4
  4. 81.2
  5. 81.1

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

11Purchases
0Sales
73Other Form 4 lines
55SEC filings · 365 days
BUYING7 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER19 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
+0.3%
3M
-8.8%
6M
-0.9%
12M
+12.7%

Volatility & liquidity

Volatility
47.1%
Beta
—
Avg daily value
USD 142.4M

Valuation

Market cap
USD 11.5B
P/E
—

Fundamentals

Profit margin
-4.9%
ROE
-3.5%
Industry
Drug Manufacturers—Specialty & Generic

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, Profit margin, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-08-03 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
37,291,528
Previous report
31,809,151
Avg daily volume
6,054,779
Days to cover
6.2

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-20Kurzius Lawrence ErikPurchase (P)Common Stock40,000USD 23.40USD 936,000SEC filing ↗
2026-08-18O'Neill ShivPurchase (P)Common Stock3,998USD 23.58USD 94,273SEC filing ↗
2026-08-12Harrington Michael JPurchase (P)Common Stock5,000USD 21.82USD 109,100SEC filing ↗
2026-08-07VanHimbergen Robert MPurchase (P)Common Stock4,200USD 23.08USD 96,936SEC filing ↗
2026-08-07Herendeen PaulPurchase (P)Common Stock10,000USD 23.69USD 236,900SEC filing ↗
2026-05-15Simmons Jeffrey NPurchase (P)Common Stock4,971USD 20.09USD 99,867SEC filing ↗
2026-05-15Modi Rajeev A.Purchase (P)Common Stock4,911USD 20.35USD 99,939SEC filing ↗
2025-12-12Kurzius Lawrence ErikPurchase (P)Common Stock10,000USD 21.30USD 213,000SEC filing ↗
2025-12-11VanHimbergen Robert MPurchase (P)Common Stock6,950USD 21.64USD 150,398SEC filing ↗
2025-12-11Simmons Jeffrey NPurchase (P)Common Stock22,000USD 21.75USD 478,500SEC filing ↗
2025-12-11Modi Rajeev A.Purchase (P)Common Stock4,500USD 21.33USD 95,985SEC filing ↗
2025-03-11Kurzius Lawrence ErikPurchase (P)Common Stock10,000USD 10.20USD 102,000SEC filing ↗
2025-03-07Kurzius Lawrence ErikPurchase (P)Common Stock10,000USD 10.90USD 109,000SEC filing ↗
2025-03-05HOOVER R DAVIDPurchase (P)Common Stock25,000USD 10.90USD 272,500SEC filing ↗
2024-08-22Harrington Michael JPurchase (P)Common Stock3,500USD 14.85USD 51,975SEC filing ↗

Form 4 evidence

84 transaction lines in the latest 365-day window; 480 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-20Kurzius Lawrence ErikPurchase (P)Common Stock40,000USD 23.40USD 936,000SEC filing ↗
2026-08-18O'Neill ShivPurchase (P)Common Stock3,998USD 23.58USD 94,273SEC filing ↗
2026-08-12Harrington Michael JPurchase (P)Common Stock5,000USD 21.82USD 109,100SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-20Kurzius Lawrence ErikPurchase (P)Common Stock40,000USD 23.40USD 936,000SEC filing ↗
2026-08-18O'Neill ShivPurchase (P)Common Stock3,998USD 23.58USD 94,273SEC filing ↗
2026-08-12Harrington Michael JPurchase (P)Common Stock5,000USD 21.82USD 109,100SEC filing ↗
2026-08-07VanHimbergen Robert MPurchase (P)Common Stock4,200USD 23.08USD 96,936SEC filing ↗
2026-08-07Herendeen PaulPurchase (P)Common Stock10,000USD 23.69USD 236,900SEC filing ↗
2026-07-07VanHimbergen Robert MTax withholding (F)Common Stock15,336USD 24.64USD 377,879SEC filing ↗
2026-05-21Scots-Knight DeniseAward / grant (A)Common Stock16,874USD 0.00USD 0SEC filing ↗
2026-05-21McDonald Kirk PAward / grant (A)Common Stock16,874USD 0.00USD 0SEC filing ↗
2026-05-21Ma StaceyAward / grant (A)Common Stock16,874USD 0.00USD 0SEC filing ↗
2026-05-21Kurzius Lawrence ErikAward / grant (A)Common Stock16,874USD 0.00USD 0SEC filing ↗
2026-05-21Kochevar Deborah TurnerAward / grant (A)Common Stock4,678USD 0.00USD 0SEC filing ↗
2026-05-21Herendeen PaulAward / grant (A)Common Stock16,874USD 0.00USD 0SEC filing ↗
2026-05-21Harrington Michael JAward / grant (A)Common Stock16,874USD 0.00USD 0SEC filing ↗
2026-05-21HOOVER R DAVIDAward / grant (A)Common Stock4,678USD 0.00USD 0SEC filing ↗
2026-05-21GARCIA ART AAward / grant (A)Common Stock16,874USD 0.00USD 0SEC filing ↗
2026-05-21Anand Kapila KAward / grant (A)Common Stock16,874USD 0.00USD 0SEC filing ↗
2026-05-15Simmons Jeffrey NPurchase (P)Common Stock4,971USD 20.09USD 99,867SEC filing ↗
2026-05-15Modi Rajeev A.Purchase (P)Common Stock4,911USD 20.35USD 99,939SEC filing ↗
2026-04-01de Brabander EllenTax withholding (F)Common Stock20,288USD 23.12USD 469,059SEC filing ↗
2026-04-01de Brabander EllenAward / grant (A)Common Stock40,985USD 0.00USD 0SEC filing ↗
2026-03-03de Brabander EllenTax withholding (F)Common Stock8,262USD 24.88USD 205,559SEC filing ↗
2026-03-03Simmons Jeffrey NTax withholding (F)Common Stock37,898USD 24.88USD 942,902SEC filing ↗
2026-03-03O'Neill ShivTax withholding (F)Common Stock4,738USD 24.88USD 117,881SEC filing ↗
2026-03-03Modi Rajeev A.Tax withholding (F)Common Stock4,392USD 24.88USD 109,273SEC filing ↗
2026-03-03Meer James MTax withholding (F)Common Stock1,389USD 24.88USD 34,558SEC filing ↗
2026-03-03McArdle GraceTax withholding (F)Common Stock4,322USD 24.88USD 107,531SEC filing ↗
2026-03-03Kinard David STax withholding (F)Common Stock3,433USD 24.88USD 85,413SEC filing ↗
2026-03-03Correia de Simas Jose ManuelTax withholding (F)Common Stock3,371USD 24.88USD 83,870SEC filing ↗
2026-03-03Cabral Ramiro MartinTax withholding (F)Common Stock6,492USD 24.88USD 161,521SEC filing ↗
2026-03-03Bettington Timothy JTax withholding (F)Common Stock4,695USD 24.88USD 116,812SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerELAN
CIK0001739104
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNYSE

Data coverage

Local Form 4 history480 transaction lines from 2020-02-01 to 2026-08-20
56 P purchase lines · 1 S sale lines · 423 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.